Literature DB >> 32091138

Minimal or reasonable? Considering the ethical threshold for research risks to nonconsenting bystanders and implications for nonconsenting participants.

Holly Fernandez Lynch1.   

Abstract

When research poses risks to non-participant bystanders, it is not always practicable to obtain their consent. One approach to assessing how much research risk may be imposed on nonconsenting bystanders is to examine analogous circumstances, including risk thresholds deemed acceptable for nonconsenting research participants and for nonconsensual risks imposed outside the research setting. For nonconsenting participants, US research regulations typically limit risks to those deemed to be "minimal." Outside the research context, US tort law tolerates a more flexible "reasonable" risk threshold. This article advances a preliminary case that nonconsenting participants and nonconsenting bystanders exposed to similar research risks may be entitled to the same level of protection, but that risks generated by research may not be special in kind. Thus, limiting research risks to those that are "reasonable," rather than demanding that they be held to the "minimal" standard, may be the best approach for both nonconsenting participants and nonconsenting bystanders. Further work is needed to establish whether the descriptive standards used to support the analogies relied on here are normatively justifiable, as well as the extent to which the minimal risk standard and the reasonable risk standard would lead to meaningfully different outcomes in practice.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  bystanders; challenge trial; minimal risk; reasonable risk; research risk; risk thresholds; third parties

Year:  2020        PMID: 32091138      PMCID: PMC8262376          DOI: 10.1111/bioe.12725

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  15 in total

Review 1.  Eliminating the daily life risks standard from the definition of minimal risk.

Authors:  D B Resnik
Journal:  J Med Ethics       Date:  2005-01       Impact factor: 2.903

2.  A normative justification for distinguishing the ethics of clinical research from the ethics of medical care.

Authors:  Paul Litton; Franklin G Miller
Journal:  J Law Med Ethics       Date:  2005       Impact factor: 1.718

3.  Rationalizing risk assessment in human subject research.

Authors:  Carl H Coleman
Journal:  Ariz Law Rev       Date:  2004

4.  Protecting third parties in human subjects research.

Authors:  David B Resnik; Richard R Sharp
Journal:  IRB       Date:  2006 Jul-Aug

5.  Ethical complexities of responding to bystander risk in HIV prevention trials.

Authors:  Nir Eyal; Daniel Wikler
Journal:  Clin Trials       Date:  2019-08-01       Impact factor: 2.486

6.  Limits to research risks.

Authors:  F G Miller; S Joffe
Journal:  J Med Ethics       Date:  2009-07       Impact factor: 2.903

7.  Public trust as a policy goal for research with human subjects.

Authors:  David B Resnik
Journal:  Am J Bioeth       Date:  2010-06       Impact factor: 11.229

8.  When and Why Is Research without Consent Permissible?

Authors:  Luke Gelinas; Alan Wertheimer; Franklin G Miller
Journal:  Hastings Cent Rep       Date:  2016-02-19       Impact factor: 2.683

9.  Setting risk thresholds in biomedical research: lessons from the debate about minimal risk.

Authors:  Annette Rid
Journal:  Monash Bioeth Rev       Date:  2014 Mar-Jun

10.  How do institutional review boards apply the federal risk and benefit standards for pediatric research?

Authors:  Seema Shah; Amy Whittle; Benjamin Wilfond; Gary Gensler; David Wendler
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.